Presented by: Mark Cannon, DDS, MS, Professor Emeritus
Original Publication Date: November 14, 2025 (AAOSH Accelerate 2025)
|
Take the Course - Coming Soon |
This course is available for CE Credit as a "Members Only" benefit. Not a Member? CLICK HERE to learn more about AAOSH Membership. |
Course Description:
This lecture explores the Black Queen Hypothesis (BQH), an evolutionary theory that explains how microbes lose costly functions and become dependent on others within their communities, creating intricate metabolic interdependencies. We will discuss the relevance of BQH to host-oral microbe interactions, focusing on how microbial loss-of-function shapes metabolic disease and insulin resistance. The session will examine gut microbiota shifts due to exercise and aging, and highlight the role of probiotics in restoring epithelial barrier integrity to mitigate leaky gut and leaky gum (disease). Clinical applications will be reviewed, including prebiotic and probiotic interventions in Parkinson’s, Autism, Alzheimer’s, cancer, and cardiovascular disease. The lecture will contrast “common goods” versus “spoiled goods” in microbial ecosystems, providing a framework for understanding microbial dependencies and therapeutic leverage points in chronic disease and aging.
Learning Objectives:
Upon completion of this lecture, participants will be able to:
Practical Applications:
Method: Lecture
Location: Online (Zoom)
AGD Course Code: 730 (Oral Medicine, Oral Diagnosis, Oral Pathology)
Credit Hours: 1
Speaker's Bio:
Mark L. Cannon, DDS is a Professor Emeritus and Attending Physician at Ann and Robert H. Lurie Children’s Hospital of Chicago, a retired Professor of Otolaryngology in the Division of Dentistry at Northwestern University Feinberg School of Medicine, and an Adjunct Professor at the University of Tennessee Health Science Center. He is the founder of Associated Dental Specialists of Long Grove (1981) and serves as Research Coordinator for the Pediatric Dental Residency Program at Lurie Children’s Hospital.
With more than 45 years of experience in pediatric dentistry, Dr. Cannon has lectured nationally and internationally at leading universities and professional organizations across North America, Europe, Asia, and South America. His areas of expertise include evolutionary oral medicine, gateway microbiomes, bioactive dental materials (patent holder), probiotics, and pediatric oral-systemic health.
Dr. Cannon is a Fellow and Diplomate of the American Academy of Pediatric Dentistry, a Master Fellow and past President (2023) of the American Academy for Oral & Systemic Health, and a member of the International Association of Pediatric Dentistry. He has been invited to both the Nobel Forum (2016) and Nobel Assembly (2017) at the Karolinska Institutet.
His current research focuses on microbiome and epigenetic influences on systemic disease, including cancer prevention through prebiotics.
Conflict of Interest:
N/A